Haiching Ma

3.7k citations

37 papers · 3.0k indexed · 2 hit papers · h-index 23

Impact in

Cell Biology top 1%
- Aldose Reductase and Taurine
Endocrinology, Diabetes and Metabolism top 2%
- Hormonal and reproductive studies
- Hormonal Regulation and Hypertension

Papers in

Cell Biology 10
- Aldose Reductase and Taurine 10
Biochemistry 4

Co-authors: Sean Deacon T.M. Penning Jeffrey R. Peterson Karthik Devarajan Theonie Anastassiadis Kapila Ratnam Joseph M. Jez Kurumi Y. Horiuchi
Journals: Biochemical Journal (4 papers)Assay and Drug Development Technologies (4 papers)Molecular Cancer Therapeutics (3 papers)Drug Design Development and Therapy (2 papers)Journal of Biological Chemistry (2 papers)
Partner nations: United States China Austria

In The Last Decade

Haiching Ma

37 papers receiving 2.9k citations

Hit Papers

align trajectories log scale

Comprehensive assay of kinase catalytic activity reveals features of kinase inhibitor selectivity 2011 · 698 citations

Peers

Countries citing papers authored by Haiching Ma

Since Specialization

Citations

This map shows the geographic impact of Haiching Ma's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haiching Ma with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haiching Ma more than expected).

Fields of papers citing papers by Haiching Ma

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haiching Ma. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haiching Ma. The network helps show where Haiching Ma may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Haiching Ma, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Haiching Ma Line = papers co-authored together Haiching Ma links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2 Journal of Biological Chemistry ·Nathan P. Coussens, Stephen C. Kales, Mark J. Henderson, Olivia W. Lee, Kurumi Y. Horiuchi, Yuren Wang, Qing Chen, Ekaterina Kuznetsova, Jianghong Wu, Sirisha Chakka, Dorian M. Cheff, Ken Cheng, Paul Shinn, Kyle R. Brimacombe, Min Shen, Anton Simeonov, Madhu Lal‐Nag, Haiching Ma, Ajit Jadhav, Matthew D. Hall	2018	55
2	Developing selective histone deacetylases (HDACs) inhibitors through ebselen and analogs Drug Design Development and Therapy ·Yuren Wang, Jason Wallach, Jhonathan Guillermo, Yuan Wang, Jianghong Wu, P Mazzola Eugene, Adeboye Adejare, Haiching Ma	2017	28
3	Comprehensive kinase profile of pacritinib, a nonmyelosuppressive Janus kinase 2 inhibitor Journal of Experimental Pharmacology ·Jack W. Singer, Suliman Al‐Fayoumi, Haiching Ma, Rami S. Komrokji, Ruben A. Mesa, Srđan Verstovšek	2016	90
4	Development and Use of Assay Conditions Suited to Screening for and Profiling of SET-Domain-Targeted Inhibitors of the MLL/SET1 Family of Lysine Methyltransferases Assay and Drug Development Technologies ·S Rosenfeld, Robert F. Smith, Pope Benedictus Vii, Erin Carr, Public Affairs Council, Jie Qian, Haiching Ma, Kurumi Y. Horiuchi, Konrad T. Howitz	2015	4
5	Identification of Histone Deacetylase Inhibitors with Benzoylhydrazide Scaffold that Selectively Inhibit Class I Histone Deacetylases Chemistry & Biology ·Yunfei Wang, Ryan L. Stowe, S. Wongratanacheevin, A. Maddison, Franck Madoux, Dawei Li, Lisa Zhao, Jian‐Liang Li, Yuren Wang, Yuan Wang, Haiching Ma, Peter Hodder, William Roush, Daiqing Liao	2015	90
6	Anilino-monoindolylmaleimides as potent and selective JAK3 inhibitors Bioorganic & Medicinal Chemistry Letters ·Mark E. McDonnell, 颖韩, Jay Wrobel, Garry R. Smith, Shuguang Liang, Haiching Ma, Allen B. Reitz	2014	15
7	Cytoprotective effect of selective small-molecule caspase inhibitors against staurosporine-induced apoptosis Drug Design Development and Therapy ·Haiching Ma, Jianghong Wu, Yuren Wang, Shuguang Liang	2014	8
8	Sorafenib Suppresses JNK-Dependent Apoptosis through Inhibition of ZAK Molecular Cancer Therapeutics ·勉小沼, Grace Ching, Sandra S. Ojeda, Charles H. Adelmann, Vida Chitsazzadeh, David Dwyer, Haiching Ma, Karin Ehrenreiter, Manuela Baccarini, Rosamaria Ruggieri, Jonathan L. Curry, Ana M. Ciurea, Madeleine Duvic, Naifa L. Busaidy, Nizar M. Tannir, Kenneth Y. Tsai	2013	25
9	Small-Molecule Inhibitors of Acetyltransferase p300 Identified by High-Throughput Screening Are Potent Anticancer Agents Molecular Cancer Therapeutics ·Heng Yang, S. Wongratanacheevin, Jian Luo, Dawei Li, Yunfei Wang, Lisa Zhao, Stephan C. Jahn, S. Adrian Saldanha, Jamie L. Planck, Kyla Geary, Haiching Ma, Brian K. Law, William Roush, Peter Hodder, Daiqing Liao	2013	82
10	Assay Development for Histone Methyltransferases Assay and Drug Development Technologies ·Kurumi Y. Horiuchi, Shin-Suk Park, S Rosenfeld, Jamie L. Planck, Erin Carr, Robert F. Smith, Konrad T. Howitz, Haiching Ma	2013	61
11	Development of Multiple Cell-Based Assays for the Detection of Histone H3 Lys27 Trimethylation (H3K27me3) Assay and Drug Development Technologies ·Jie Qian, Lihui Lü, Jianghong Wu, Haiching Ma	2013	8
12	Fluorescence Polarization and Time-Resolved Fluorescence Resonance Energy Transfer Techniques for PI3K Assays Methods in molecular biology ·Kurumi Y. Horiuchi, Haiching Ma	2009	3
13	The challenge of selecting protein kinase assays for lead discovery optimization Expert Opinion on Drug Discovery ·Haiching Ma, Sean Deacon, Kurumi Y. Horiuchi	2008	161
14	Microarrays for the Functional Analysis of the Chemical-Kinase Interactome SLAS DISCOVERY ·Kurumi Y. Horiuchi, Yuan Wang, Scott L. Diamond, Haiching Ma	2006	31
15	Nanoliter Homogenous Ultra-High Throughput Screening Microarray for Lead Discoveries and IC ₅₀ Profiling Assay and Drug Development Technologies ·Haiching Ma, Kurumi Y. Horiuchi, Yuan Wang, Agustina Uktolseja, Scott L. Diamond	2005	31
16	Biochemical Microarrays for Studying Chemical Biology Interaction: DiscoveryDot^TM Technology Chemical Biology & Drug Design ·Kurumi Y. Horiuchi, Yuan Wang, Haiching Ma	2005	3
17	Nonviral Gene Therapy and its Delivery Systems Current Pharmaceutical Biotechnology ·Haiching Ma, Scott L. Diamond	2001	42
18	Adenovirus or HA‐2 fusogenic peptide‐assisted lipofection increases cytoplasmic levels of plasmid in nondividing endothelium with little enhancement of transgene expression The Journal of Gene Medicine ·Wenqiang Dun, Haiching Ma, Kris Noel Dahl, Jingya Zhu, Scott L. Diamond	2001	22
19	Human 3α-hydroxysteroid dehydrogenase isoforms (AKR1C1‒AKR1C4) of the aldo-keto reductase superfamily: functional plasticity and tissue distribution reveals roles in the inactivation and formation of male and female sex hormones Biochemical Journal ·T.M. Penning, Michael E. Burczynski, Joseph M. Jez, Chien‐Fu Hung, Angie Tatiana Casadiego Hurtado, Haiching Ma, Margaret Moore, Nisha Palackal, Kapila Ratnam Hit paper breakdown →	2000	505
20	Steroid recognition and regulation of hormone action: crystal structure of testosterone and NADP+ bound to 3α-hydroxysteroid/dihydrodiol dehydrogenase Structure ·M. J. Bennett, Ross H. Albert, Joseph M. Jez, Haiching Ma, T.M. Penning, 潤塚原	1997	104

About Haiching Ma

Haiching Ma is a scholar working on Cell Biology, Biochemistry, Endocrinology, Diabetes and Metabolism, Molecular Biology and Genetics, having authored 37 papers that have together received 3.0k indexed citations. Recurring topics across this work include Aldose Reductase and Taurine (10 papers), Epigenetics and DNA Methylation (5 papers), Computational Drug Discovery Methods (4 papers), Prenatal Substance Exposure Effects (4 papers), Advanced Biosensing Techniques and Applications (4 papers), Histone Deacetylase Inhibitors Research (4 papers), Cancer-related gene regulation (4 papers) and Monoclonal and Polyclonal Antibodies Research (4 papers). The work is most often cited by research in Cell Biology (853 citations), Endocrinology, Diabetes and Metabolism (552 citations), Molecular Biology (1.7k citations), Computational Theory and Mathematics (306 citations) and Genetics (165 citations). Haiching Ma has collaborated with scholars based in United States, China and Austria. Frequent co-authors include Sean Deacon, T.M. Penning, Jeffrey R. Peterson, Karthik Devarajan, Theonie Anastassiadis, Kapila Ratnam, Joseph M. Jez, Kurumi Y. Horiuchi, Michael E. Burczynski and Margaret Moore. Their work appears in journals such as Biochemical Journal, Assay and Drug Development Technologies, Molecular Cancer Therapeutics, Drug Design Development and Therapy and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact